Trial Report REGENECYTE cord blood cell therapy in post-COVID syndrome: a phase IIa randomized, placebo-controlled trial, 2026, Huang et al

No—Topol is actually (shockingly) being good/helpful here. He is criticizing Attia for hawking this bogus AG-1 supplement and these David protein bars, etc.

“Moreover, these days you are riddled with conflicts as a huckster for David Bars, AG-1 supplement, and so many other things that diminish your credibility. That's a shame.”
 
Back
Top Bottom